tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Kazia Therapeutics signs collaboration and in-licensing agreement for PD-L1
PremiumThe FlyKazia Therapeutics signs collaboration and in-licensing agreement for PD-L1
24d ago
Kazia Therapeutics Reports Significant Tumor Reduction in TNBC Patient with Paxalisib
Premium
Company Announcements
Kazia Therapeutics Reports Significant Tumor Reduction in TNBC Patient with Paxalisib
29d ago
Kazia Therapeutics price target raised to $20 from $15 at Maxim
Premium
The Fly
Kazia Therapeutics price target raised to $20 from $15 at Maxim
29d ago
Kazia Therapeutics Achieves Breakthrough in Breast Cancer Treatment with Paxalisib
PremiumCompany AnnouncementsKazia Therapeutics Achieves Breakthrough in Breast Cancer Treatment with Paxalisib
2M ago
Kazia Therapeutics’ paxalisib monotherapy shows tumor cell cluster disruption
Premium
The Fly
Kazia Therapeutics’ paxalisib monotherapy shows tumor cell cluster disruption
2M ago
Kazia Therapeutics Secures $2 Million in Private Placement to Advance Oncology Programs
Premium
Company Announcements
Kazia Therapeutics Secures $2 Million in Private Placement to Advance Oncology Programs
3M ago
Kazia Therapeutics Announces Promising Early Results in Breast Cancer Trial
PremiumCompany AnnouncementsKazia Therapeutics Announces Promising Early Results in Breast Cancer Trial
4M ago
Kazia Therapeutics reports preliminary results from Phase 1b trial
Premium
The Fly
Kazia Therapeutics reports preliminary results from Phase 1b trial
4M ago
Kazia Therapeutics trading halted, volatility trading pause
Premium
The Fly
Kazia Therapeutics trading halted, volatility trading pause
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100